Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BIVALIRUDIN vs DALTEPARIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BIVALIRUDIN vs DALTEPARIN: Safety Overview

Metric BIVALIRUDIN DALTEPARIN
Total FAERS Reports 839 3,570
Deaths Reported 137 789
Death Rate 16.3% 22.1%
Hospitalizations 249 1,443
Average Patient Age 53.2 yrs 67.7 yrs
% Female Patients 33.7% 39.7%
FDA Approval Date Dec 15, 2000 Apr 4, 2002
Manufacturer Meitheal Pharmaceuticals Inc. Pfizer Laboratories Div Pfizer Inc
Route INTRAVENOUS SUBCUTANEOUS
Marketing Status Prescription Prescription